Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New study reveals BA.2.86 subvariant's surprising dance with antibodies

Researchers examined the antigenicity of the emerging SARS-CoV-2 subvariant BA.2.86, finding that it is not resistant to neutralizing antibodies from previously infected or vaccinated individuals, although it does show increased binding affinity to the ACE-2 receptor. The study highlights the subvariant's sensitivity and resistance to different classes of monoclonal antibodies, offering insights for future treatment and vaccine development.

2 Oct 2023

Ginger shows promise as a natural defense against autoimmune diseases

Comprehensive study reveals that whole ginger extracts have a significant impact on inhibiting neutrophil hyperactivity, a key factor in autoimmune diseases like APS and lupus. Consuming ginger for just a week showed promising results in both animal models and human trials, positioning it as a natural and affordable treatment option for a range of autoimmune disorders.

2 Oct 2023

Maternal COVID-19 shots significantly lowered infant hospitalizations during Omicron wave

Study found that maternal COVID-19 vaccination during pregnancy significantly reduces the risk of COVID-19-related hospitalizations in infants under six months, particularly boosting protection during the first three months of life. With 78% of the hospitalized infants born to unvaccinated mothers, the research emphasizes the crucial role of maternal vaccination in safeguarding infants too young for vaccination.

2 Oct 2023

New study reveals alarming cardiovascular risks from COVID

The study published in Nature Cardiovascular Research reveals that SARS-CoV-2, the virus causing COVID-19, can directly infect coronary vessels and arterial plaques, heightening the risk of cardiovascular complications like heart attacks and strokes. These findings offer critical insights into the increased long-term cardiovascular risks for COVID-19 survivors and open new avenues for targeted therapies.

1 Oct 2023

These Appalachia hospitals made big promises to gain a monopoly. They’re failing to deliver.

Five years ago, rival hospital companies in this blue-collar corner of Appalachia made a deal. If state lawmakers let them merge, leaving no competitors, the hospitals promised not to gouge prices or cut corners.

29 Sep 2023

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.

28 Sep 2023

Primate model unlocks clues to long-COVID's impact on blood sugar, hints at vaccine benefits

The study uses a non-human primate model to explore the link between long-COVID and disruptions in glucose metabolism, finding a positive correlation. Vaccination appeared to improve glycemic control, suggesting a possible role in managing long-COVID symptoms.

28 Sep 2023

Zoom backgrounds matter: Plants and bookshelves elevate trust!

This recent study explores how gender, facial expression, and video backgrounds influence first impressions of competence and trustworthiness during video conferences. The findings suggest that happy faces are generally perceived as more competent and trustworthy, females are often viewed as more trustworthy and competent, and certain backgrounds like bookcases and plants boost perceptions of competence.

28 Sep 2023

Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered

Study highlights the ability of the Vaxzevria vaccine in inducing robust mucosal antibody responses, especially in COVID-19-recovered individuals, showcasing a notable defense against various SARS-CoV-2 variants. However, it emphasizes the need for booster doses to enhance anti-SARS-CoV-2 mucosal immunity, especially in infection-naïve individuals, to broaden protection against emerging viral variants.

28 Sep 2023

SARS-CoV-2 virus can trigger dangerous immune response in artery-clogging plaques

In some patients, infection with the pandemic virus SARS-CoV-2 can trigger a dangerous immune response in hardened fatty deposits (plaques) lining the heart's largest blood vessels, a new study shows.

28 Sep 2023

Virtual reality vs. opioids: clinical trial of non-pharmacological pain management during burn wound care

Researchers assessed the feasibility and efficacy of virtual reality as a non-pharmaceutical intervention for managing procedural pain in adult burn patients during dressing changes compared to standard opioid-based approaches.

28 Sep 2023

US health care workers are at greater risk of suicide than non–health care workers

The risks of death by suicide for six healthcare worker (HCW).

28 Sep 2023

Mutations on a key SARS-CoV-2 viral protein linked to extreme immune responses

Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.

27 Sep 2023

KFF Health News' 'What the Health?': More Medicaid messiness

Federal officials have instructed at least 30 states to reinstate Medicaid and Children's Health Insurance Program coverage for half a million people, including children, after an errant computer program wrongly determined they were no longer eligible.

27 Sep 2023

As covid infections rise, nursing homes are still waiting for vaccines

"Covid is not pretty in a nursing home," said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She twice contracted the disease and is eager to get the newly approved vaccine because she has chronic lymphocytic leukemia, which weakens her immune system.

27 Sep 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New study reveals BA.2.86 subvariant's surprising dance with antibodies

Ginger shows promise as a natural defense against autoimmune diseases

Maternal COVID-19 shots significantly lowered infant hospitalizations during Omicron wave

New study reveals alarming cardiovascular risks from COVID

These Appalachia hospitals made big promises to gain a monopoly. They’re failing to deliver.

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Primate model unlocks clues to long-COVID's impact on blood sugar, hints at vaccine benefits

Zoom backgrounds matter: Plants and bookshelves elevate trust!

Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered

SARS-CoV-2 virus can trigger dangerous immune response in artery-clogging plaques

Virtual reality vs. opioids: clinical trial of non-pharmacological pain management during burn wound care

US health care workers are at greater risk of suicide than non–health care workers

Mutations on a key SARS-CoV-2 viral protein linked to extreme immune responses

KFF Health News' 'What the Health?': More Medicaid messiness

As covid infections rise, nursing homes are still waiting for vaccines

Surrey researchers develop new rapid electronic diagnostic test for infectious diseases

Zoonotic spillover safeguarding: computationally designed antigen targets range of coronaviruses

Medication and mutations: molnupiravir's impact on SARS-CoV-2 genomes

Long COVID's biological blueprint: new study offers promising insights

Could baseline gut microbiota predict the immune responses elicited by COVID-19 vaccines?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in